Paired tumor-normal comparisons further confirmed CD58 upregulation in ESCA, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, LUSC, stomach adenocarcinoma (STAD), and thyroid carcinoma (THCA) (Figure 1B). This evidence concerns the gene CD58 and neoplasm.